Introduction
Despite therapeutic advances, patients with STEMI are at particular risk of other cardiovascular events in the first few months following their infarct. 1 Several irreversible risk factors have been identified for these late complications including advanced age, male gender, 2 biochemical markers of myocardial injury 3, 4 and a low left ventricular ejection fraction. 5 Potentially reversible risk factors including recurrent ischaemia 6, 7 and autonomic dysfunction are also known to predispose to an increase in morbidity post-STEMI. [8] [9] [10] Heart rate variability (HRV), a measure of autonomic function, is an independent predictor of poor prognosis in patients surviving a STEMI, 8 with sudden cardiac death often preceded by changes in autonomic activity. 11 Reduction in HRV occurs immediately following acute myocardial infarction and can remain suppressed for days to months. 9 Attenuated HRV post-STEMI is likely to reflect a decrease in vagal activity thereby leading to augmented sympathetic activity and to generalized cardiac electrical instability. These characteristics may reflect a saturating influence on the sinus node of persistently high sympathetic tone. 11 Previous studies have confirmed that premature cardiac mortality is markedly increased in patients with an attenuated HRV following acute myocardial infarction. 12, 13 However, there have been few studies examining factors that may influence autonomic dysfunction in the peri-infarct period and their impact on the risk of longer term cardiovascular events. 14, 15 Previously, we have reported that, in individuals without overt cardiovascular or structural heart disease and also in people with type 1 diabetes, significant increases in autonomic function (as measured by improvement in HRV) occur following introduction of caffeine in amounts equivalent to 'normal' daily ingestion. 16 Coffee drinking is common in nearly every country in the world with an average intake of two cups each day. 17 A number of benefits from ingesting coffee have been suggested including increasing antioxidant levels, prevention of oxidation of LDLcholesterol and inhibition of platelet aggregation. 18 In contrast, drinking coffee has also been associated with transient increases in blood pressure and homocysteine levels although most studies have suggested no increase risk of developing coronary heart disease with regular coffee drinking. [19] [20] [21] [22] [23] The aim of this study was to assess the influence of caffeine on autonomic function following an acute STEMI.
Methods
Following Local Ethics Committee approval, 103 patients admitted to the Coronary Care Unit between September 2004 and September 2006 with STEMI were recruited within 48 h of their event ( Figure 1 ). They were eligible for the study if they had evidence of STEMI according to the Joint European Society of Cardiology/American College of Cardiology criteria 24 by the typical enzyme patterns/troponin changes and diagnostic electrocardiographic changes in the presence of sinus rhythm. Patients were excluded if they displayed any of the following criteria: cardiogenic shock, were 'nil-by-mouth', had caffeine intolerance, atrial fibrillation, required temporary or permanent pacing, complete heart block, inotropic support, concomitant diseases or conditions that could alter the analysis of HRV such as long-standing type 1 diabetes or severely impaired left ventricular function (ejection fraction <30%).
After providing written consent, patients were randomized to either coffee or de-caffeinated coffee. Free access to standardized cups of instant coffee was provided (calculated to contain 75 mg of caffeine). All patients were provided with a low caffeine diet for the duration of the study, irrespective of the provision of de-caffeinated or regular coffee. Randomization was blinded to both participant and HRV analysers. On Day 5 AE 2 of admission, participants underwent 24 h monitoring of HRV, which was subsequently analysed by a single, blinded observer (CM).
Assessing HRV
A 24-h ambulatory ECG with a miniature digital recorder (Tracker, Reynolds Medical Ltd) was used together with a crystal generated time reference track that allowed for recording and replay speed errors to within 0.5%. Recordings were replayed through a Pathfinder 700 arrhythmia analyser (Reynolds Medical Ltd) to identify ventricular arrhythmias (>10 ventricular beats per hour), or the occurrence of couplets or runs of non-sustained ventricular tachycardia. Tracings of >16 h, with >95% of the recording suitable, were used in the analysis of HRV. After initial arrhythmia analysis, the remaining normal-to-normal RR intervals were measured and the time-domain analysis of HRV carried out as previously described. 16 For the purpose of this study, four different indices of HRV were measured:
(i) the number of increases in successive normalto-normal RR intervals >50 ms (sNN50), (ii) the standard deviation (SD) of all normal-tonormal RR intervals in the entire 24 h recording (SDNN), (iii) the mean of all SDs of R-R intervals (SDNN index) and (iv) the root mean square of the differences between adjacent normal-to-normal RR intervals in the 24-h recording (RMSSD).
Higher heart rates indicate poor autonomic function and low fitness and are not specific for autonomic dysfunction. SDNN represents joint sympathetic and parasympathetic modulation of heart rate, whereas sNN50 and RMSSD represent parasympathetic modulation of heart rate. 25 
Spectral analysis
Power spectral analysis was computed by fastFourier transformation of the first 300 s of each hour of the 24 h recording period. Ectopic beats and movement artefacts were excluded by application of the Hamming window and by visual assessment. The following frequency domain measures were assessed: (i) the low-frequency power (LF, 0.04-0.15 Hz); (ii) the high-frequency power (HF, 0.15-0.4 Hz); (iii) the LF/HF ratio. For this study, the HF was used as a marker of parasympathetic activity and the LF/HF for sympathetic activity. 25 
Echocardiographic evaluation
All patients underwent echocardiographic evaluation 24-48 h post-STEMI using 2 or 3.5 mHz transducers (HP Sonos 5000, USA). Left ventricular function was assessed by measuring the ejection fraction calculated using the bi-plane area-length method for two consecutive cardiac cycles. Ejection fraction was evaluated as a continuous and as a categorical variable (ejection fraction <30 or >30%).
Follow-up
A notes review was undertaken 1 year after the last patient had been recruited. The observer was blinded as to intake of coffee or de-caffeinated coffee and the results analysed independently. Average follow-up period was 22 months (range 12-34 months). Outcome parameters were defined as death, STEMI/NSTEMI (fatal or non-fatal), revascularisation procedures (CABG or percutaneous transluminal coronary angioplasty) or admission into hospital with cardiac chest pain or pulmonary oedema.
Sample size and statistical analysis
Statistical analysis was performed through SPSS-Win 10.1 (Statistical Package for Social Science, SPSS Inc., Chicago, IL, USA) with a 5% significance level. For HRV data that were approximately normally distributed the independent samples t-test was used to compare means between the two groups. If the data were not normally distributed the Mann-Whitney U-test was used. One hundred and three patients were randomized, and 70 had complete HRV data. No sample size calculation was done a priori. However, with the sample size achieved, for continuous variables such as HRV, the study has 80% power to detect standardized effect sizes of 0.7 or more using a 5% significance level.
Results
The primary analysis was of HRV on the 5th day post-STEMI. Secondary end-points were cardiovascular complications and deaths from any cause within 12 months following STEMI (Table 3) . Average ingestion of the beverages was 4.7 AE 1.1 cups per day in the coffee group (average daily caffeine ingestion 352.5 AE 90 mg) and 4.5 AE 1.3 cups per day in the de-caffeinated coffee group. Patient details are shown below (Table 1) .
HRV
There was an overall improvement in autonomic function with regular coffee, with significant increases in measures of parasympathetic activity of up to 96% (Table 2) . Spectral analysis suggested a more marked improvement in HRV post-STEMI with regular coffee in those patients who had previously been low caffeine users (<150 mg per day equivalent to 2 or less cups of instant coffee daily, N = 31 of 103 study participants), although this did There was no difference in heart rate between the two groups, nor was there any significant deleterious effect of regular coffee on premature aberrant beats, rates of supra-ventricular tachycardia, atrial fibrillation, atrial or ventricular couplets, triplets or ventricular tachycardias. These results were independent of whether the patients were taking b-blockers or ACE inhibitors-drugs known to affect HRV. Data normally distributed so presented as mean (SD) and compared between groups using the independent samples t-test.
b Data skewed so presented as median (IQR) and compared between groups using the Mann-Whitney U-test. SD: standard deviation; sNN50: number of increases in successive normal-to-normal RR intervals >50 ms; SDNN: standard deviation (SD) of all normal-to-normal RR intervals in the entire 24 h recording; SDNNi: mean of all SDs of R-R intervals; RMSSD: root mean square of the differences between adjacent normal-to-normal RR intervals in the 24-h recording.
Post-discharge events
Follow-up details were available through hospital records for 49 of the 51 subjects in the placebo group and 51 of the 52 subjects in the caffeine group for at least 12 months post-infarct. The number of outcome parameters in the caffeine and placebo groups, respectively were death (1,1), STEMI/NSTEMI (fatal or non-fatal) (7,6), revascularization procedures (CABG or percutaneous transluminal coronary angioplasty) (23, 17) or admission into hospital with cardiac chest pain or pulmonary oedema (23, 18) . There was no statistically significant difference between those randomized to regular coffee or de-caffeinated coffee with regards to cardiovascular complications, although numbers of complications were small (Table 3 ).
Discussion
Previous large prospective studies have suggested that habitual consumption of caffeinated coffee does not increase the risk of cardiovascular events even in high-risk population including people with diabetes. 23 Here, acute ingestion of modest amounts of coffee (average caffeine load 353 mg, equivalent to 4-5 cups of coffee per day) in patients with acute ST elevation myocardial infarction was associated with improvement in HRV 5 days after the event with no short-term adverse consequences.
This effect was irrespective of the habitual/nonhabitual usage of regular coffee prior to admission with STEMI. Commonly, autonomic function is reduced post-ST elevation myocardial infarction 8 with a shift of sympathovagal balance towards a sympathetic predominance and a reduced vagal tone. Depressed HRV has been shown to be a powerful predictor of subsequent premature mortality in patients surviving an acute myocardial infarction, suggesting that the imbalance in the sympathetic/ parasympathetic system may facilitate the emergence of ventricular arrhythmias. 27, 28 In previous studies, reduced parasympathetic activity in particular, were associated with an unfavourable cardiovascular outcome, 27 and identified a high-risk population of patients having subsequent coronary events, often some months after an apparent clinical stabilization.
The SD of all normal RR intervals in the entire 24-h electrocardiographic recording (SDNN) and the SD of the means of all normal RR intervals (SDANN) indices are measures of both parasympathetic and sympathetic tone as mediated by the baroreflex activity. The sum of successive NN intervals >50 ms (sNN50) and the root-mean square of differences of successive RR intervals (RMSSD) are a measure of the modulation of parasympathetic tone, and were most influenced in this study by caffeine ingestion. Coffee attenuated this depression in HRV, probably through an augmentation in parasympathetic activity. Available data suggest that depressed HRV is not a simple reflection of sympathetic overdrive and/or vagal withdrawal due to poor ventricular performance but that it also reflects depressed vagal activity, which has a strong association with the pathogenesis of ventricular arrhythmias and sudden cardiac death. 29 It is not known if modification of HRV translates directly into cardiac protection, although it has been suggested that increases in vagal activity can be beneficial. 27 It is not yet established whether depressed HRV is part of the mechanism of increased post-infarction mortality or is merely a marker of poor prognosis. We also found no adverse cardiovascular effects associated with caffeine ingestion peri-infarct, in particular no predisposition to tachydysrhythmias. The present study was not powered to detect differences in clinical end-points, in particular sudden death.
Limitations of the study
There were a number of uninterpretable 24-h HRV analyses due to post-STEMI dysrhythmias including multiple ventricular ectopic activity and a trial fibrillation as well as poor quality recordings. This reduced the power of the study although the analysis drop-out rates were similar between the groups. A much larger study would be required to assess the influence of caffeine on cardiovascular complications post-STEMI.
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